Loading...
XNASNAII
Market cap26mUSD
Jan 10, Last price  
4.21USD
1D
-0.23%
1Q
-10.98%
Jan 2017
-62.74%
Name

Natural Alternatives International Inc

Chart & Performance

D1W1MN
XNAS:NAII chart
P/E
P/S
0.23
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
-3.72%
Rev. gr., 5y
-3.82%
Revenues
114m
-26.11%
91,492,00099,131,00097,128,00081,755,00073,919,00065,553,00055,882,00072,822,00062,797,00073,942,00079,508,000114,201,000121,946,000132,437,000138,290,000118,876,000178,520,000170,966,000154,015,000113,796,000
Net income
-7m
L
2,199,0002,670,000-5,285,000-371,000-4,080,0004,127,0005,086,0004,158,0001,570,0001,994,0003,346,0009,546,0007,235,0005,051,0006,541,000-1,645,00010,768,00010,712,0002,522,000-7,217,000
CFO
-1m
L
2,518,000-3,816,00015,058,0002,688,0004,887,0007,088,0009,087,0001,730,0004,470,0005,347,0002,678,0009,285,00014,137,0001,833,0006,564,0003,691,00020,806,00011,866,0007,019,000-1,497,000
Earnings
Feb 11, 2025

Profile

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
IPO date
Jan 13, 1997
Employees
356
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
113,796
-26.11%
154,015
-9.91%
170,966
-4.23%
Cost of revenue
124,230
152,826
159,907
Unusual Expense (Income)
NOPBT
(10,434)
1,189
11,059
NOPBT Margin
0.77%
6.47%
Operating Taxes
(2,247)
1,033
2,947
Tax Rate
86.88%
26.65%
NOPAT
(8,187)
156
8,112
Net income
(7,217)
-386.16%
2,522
-76.46%
10,712
-0.52%
Dividends
Dividend yield
Proceeds from repurchase of equity
(221)
(1,503)
(5,503)
BB yield
0.63%
3.55%
8.56%
Debt
Debt current
4,890
2,760
302
Long-term debt
103,063
49,583
53,587
Deferred revenue
Other long-term liabilities
881
1,326
1,462
Net debt
95,972
38,207
31,603
Cash flow
Cash from operating activities
(1,497)
7,019
11,866
CAPEX
(3,017)
(13,524)
(26,488)
Cash from investing activities
(3,017)
(13,467)
(26,458)
Cash from financing activities
2,891
(1,781)
4,292
FCF
(31,392)
(8,862)
(15,037)
Balance
Cash
11,981
13,604
21,833
Long term investments
532
453
Excess cash
6,291
6,435
13,738
Stockholders' equity
73,037
80,191
79,449
Invested Capital
137,476
114,219
107,912
ROIC
0.14%
8.54%
ROCE
0.99%
9.00%
EV
Common stock shares outstanding
5,871
5,878
6,155
Price
6.02
-16.39%
7.20
-31.03%
10.44
-37.97%
Market cap
35,343
-16.48%
42,318
-34.14%
64,259
-40.15%
EV
131,315
80,525
95,862
EBITDA
(5,787)
5,439
15,224
EV/EBITDA
14.81
6.30
Interest
361
451
83
Interest/NOPBT
37.93%
0.75%